SlideShare a Scribd company logo
GENERAL ANAESTHETIC
By-: KARTIK TIWARI
● Outline-:
● General introduction
● Classification of general anaesthetic
● Mode of action
● Stages of anaesthesia
● Drugs
- Uses
- Contradiction
- Dosage
- Adverse effect
★ General introduction
● Definition-:General anaesthetic is defined as the chemical
agent which causes reversible loss of sensation or
unconscious the whole body.
● General anaesthetic is used to unconscious the whole body.
● It act on Central nervous system (CNS) and peripheral parts
of the body.
● The characteristics of general anaesthetic are:
1. Unconsciousness
2. Amnesia
3. immobilisation and muscle relaxant.
★ Classification of general anaesthetic
General anaesthetic
Inhalant Injectable
Gaseous Voletile liquids Fast acting drugs Slow acting drugs
Benzodiazepines Opioid
analgesic
Dissociative
anaesthetic
Nitrous oxide Ether
Halothane
Isoflurane
Desflurane
Sevoflurane
Thiopentone sod.
Methohexitone
sod.
Propofol
Etomidate
Diazepam
Lorazepam
Midazolam
Ketamine
Fentanyl
● N2O and ketamine do not affect GABA or glycine gated Cl¯ channels.
Rather they selectively inhibit the excitatory NMDA type of glutamate
receptor. This receptor gates mainly Ca2+ selective cation channels in
the neurones, inhibition of which appears to be the primary mechanism
of anaesthetic action of keta-mine as well as N2O. The volatile
anaesthetics have little action on this receptor.
● Mode of action
● Inhalational anaes-thetics, barbiturates, benzodiazepines and propofol
potentiate the action of inhibitory transmitter GABA to open Cl¯
channels.
★ Stages of anaesthesia
Modern anesthetics act very rapidly and achieve deep anesthesia quickly.
With older and more slowly acting anesthetics, the progressively greater
depth of central depression associated with increasing dose or time of
exposure is traditionally described as stages of anesthesia.
A. Stage 1: Analgesia
In stage 1, the patient has decreased awareness of pain, sometimes
with amnesia. Consciousness may be impaired but is not lost.
B. Stage 2: Disinhibition
In stage 2, the patient appears to be delirious and excited. Amnesia
occurs, reflexes are enhanced, and respiration is typically irregular;
retching and incontinence may occur.
C. Stage 3: Surgical Anesthesia
In stage 3, the patient is unconscious and has no pain reflexes;
respiration is very regular, and blood pressure is maintained.
D. Stage 4: Medullary Depression
In stage 4, the patient develops severe respiratory and cardiovascular
depression that requires mechanical and pharmacologic support.
★ Drugs
Halothane
Form - Volatile liquid
● Uses:
Induction and maintenance of anaesthesia
● Contraindications:
History of unexplained jaundice or pyrexia following previous exposure to
halothane; family history of malignant hyperthermia; raised cerebrospinal
fluid pressure; porphyria
● Precautions:
Anaesthetic history should be carefully taken to determine previous
exposure and revious reactions to halothane (at least 3 months should be
allowed to elapse between each re-exposure); avoid for dental procedures
in patients under 18 years unless treated in hospital (high risk of
arrhythmias); pregnancy and breastfeeding
● Dosage:
Induction, using specifically calibrated vaporizer, gradually increase inspired
gas concentration to 2–4% (ADULT ) or 1.5–2% (CHILD ) in oxygen or
nitrous oxide–oxygen
Maintenance, ADULT and CHILD 0.5–2%
● Adverse effects:
arrhythmias; bradycardia; respiratory depression; hepatic damage
Nitrous oxide
Form - Inhalation gas
● Uses:
Maintenance of anaesthesia in combination with other anaesthetic agents
(halothane, ether, or ketamine) and muscle relaxants; analgesia for
obstetric practice, for emergency management of injuries, during
postoperative physiotherapy and for refractory pain in terminal illness
● Contraindications:
Demonstrable collection of air in pleural, pericardial or peritoneal space;
intestinal obstruction; occlusion of middle ear; arterial air embolism;
decompression sickness; chronic obstructive airway disease, emphysema
● Dosage:
Anaesthesia, Adult and Child nitrous oxide mixed with 25–30% oxygen
Analgesia, 50% nitrous oxide mixed with 50% oxygen
● Adverse effects:
nausea and vomiting; after prolonged administration megaloblastic
anaemia, depressed white cell formation; peripheral neuropathy
Thiopental sodium
Thiopental is a representative intravenous anaesthetic. Various drugs can
serve as alternatives Injection (Powder for solution for injection), thiopental
sodium, 0.5-g and 1-g ampoules.
● Uses:
Induction of anaesthesia prior to administration of inhalational anaesthetic;
anaesthesia of short duration
● Contraindications:
Inability to maintain airway; hypersensitivity to barbiturates;
● Dosage:
Induction, by intravenous injection as a 2.5% (25 mg/ml) solution over
10–15 seconds, Adult 100–150 mg (reduced in elderly or debilitated
patients), followed by a further 100–150 mg if necessary according to
response after 60 seconds; or up to 4 mg/kg; Child 2–7 mg/kg repeated if
necessary according to response after 60 seconds.
Form - Volatile liquid
● Uses:
Induction and maintenance of anaesthesia (administered from many types
of vaporizers)
● Contraindications:
severe liver disease; diabetes mellitus; impaired kidney function; raised
cerebrospinal fluid pressure.
Ether, anaesthetic
● Dosage:
Induction, Adult and Child , up to 15% in inspired gases
Maintenance of light anaesthesia, Adult and Child 3–5% in air (with or
without muscle relaxants); up to 10% for deep anaesthesia
● Adverse effects:
transient postoperative effects include impairment of liver function and
leukocytosis; nausea and vomiting; capillary bleeding.

More Related Content

What's hot

Emergency drugs
Emergency drugsEmergency drugs
Emergency drugs
Manu Mehta
 
Parasympathomimetic agents
Parasympathomimetic agentsParasympathomimetic agents
Parasympathomimetic agents
Kirti Vadi
 
Antidepressants
Antidepressants Antidepressants
Antidepressants
http://neigrihms.gov.in/
 
CNS stimulants
CNS stimulantsCNS stimulants
CNS stimulants
Shagufta Farooqui
 
Pharmacology of adrenergic neuron blockers
Pharmacology of adrenergic neuron blockersPharmacology of adrenergic neuron blockers
Pharmacology of adrenergic neuron blockers
Shahan Ullah
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacology
pavithra vinayak
 
Pharmacology of dopamine
Pharmacology of dopaminePharmacology of dopamine
Pharmacology of dopamine
sumitwankh
 
3.4 alcohol & disulfiram
3.4 alcohol & disulfiram3.4 alcohol & disulfiram
3.4 alcohol & disulfiram
Arunachalam Muthuraman
 
Anticonvulsant drugs
Anticonvulsant  drugsAnticonvulsant  drugs
Anticonvulsant drugs
Anirban Sarkar
 
pharmacotherapy of anxiety
pharmacotherapy of anxietypharmacotherapy of anxiety
pharmacotherapy of anxiety
Jayant Patwa
 
analgesics and anti inflammatory drugs - Session 1
analgesics and anti inflammatory drugs - Session 1analgesics and anti inflammatory drugs - Session 1
analgesics and anti inflammatory drugs - Session 1
Suman Mukherjee
 
Antiadrenergic Drugs
Antiadrenergic DrugsAntiadrenergic Drugs
Antiadrenergic Drugs
Darya Daoud
 
Antitubercular drugs
Antitubercular drugsAntitubercular drugs
Antitubercular drugs
Dr. Pramod B
 
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASEANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
Kameshwaran Sugavanam
 
Poisoning & Drug overdose
Poisoning & Drug overdosePoisoning & Drug overdose
Poisoning & Drug overdose
BikashAdhikari26
 
pharmacology of myasthenia gravis
pharmacology of myasthenia gravispharmacology of myasthenia gravis
pharmacology of myasthenia gravis
Koppala RVS Chaitanya
 
Drugs used in Congestive heart failure
Drugs used in Congestive heart failure Drugs used in Congestive heart failure
Drugs used in Congestive heart failure
shoaib241087
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepilepticsraj kumar
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
Kameshwaran Sugavanam
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
Kalaivanisathishr
 

What's hot (20)

Emergency drugs
Emergency drugsEmergency drugs
Emergency drugs
 
Parasympathomimetic agents
Parasympathomimetic agentsParasympathomimetic agents
Parasympathomimetic agents
 
Antidepressants
Antidepressants Antidepressants
Antidepressants
 
CNS stimulants
CNS stimulantsCNS stimulants
CNS stimulants
 
Pharmacology of adrenergic neuron blockers
Pharmacology of adrenergic neuron blockersPharmacology of adrenergic neuron blockers
Pharmacology of adrenergic neuron blockers
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacology
 
Pharmacology of dopamine
Pharmacology of dopaminePharmacology of dopamine
Pharmacology of dopamine
 
3.4 alcohol & disulfiram
3.4 alcohol & disulfiram3.4 alcohol & disulfiram
3.4 alcohol & disulfiram
 
Anticonvulsant drugs
Anticonvulsant  drugsAnticonvulsant  drugs
Anticonvulsant drugs
 
pharmacotherapy of anxiety
pharmacotherapy of anxietypharmacotherapy of anxiety
pharmacotherapy of anxiety
 
analgesics and anti inflammatory drugs - Session 1
analgesics and anti inflammatory drugs - Session 1analgesics and anti inflammatory drugs - Session 1
analgesics and anti inflammatory drugs - Session 1
 
Antiadrenergic Drugs
Antiadrenergic DrugsAntiadrenergic Drugs
Antiadrenergic Drugs
 
Antitubercular drugs
Antitubercular drugsAntitubercular drugs
Antitubercular drugs
 
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASEANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
ANTI ALZHEIMER'S AGENTS / DRUGS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE
 
Poisoning & Drug overdose
Poisoning & Drug overdosePoisoning & Drug overdose
Poisoning & Drug overdose
 
pharmacology of myasthenia gravis
pharmacology of myasthenia gravispharmacology of myasthenia gravis
pharmacology of myasthenia gravis
 
Drugs used in Congestive heart failure
Drugs used in Congestive heart failure Drugs used in Congestive heart failure
Drugs used in Congestive heart failure
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 

Similar to General anaesthetic

General anaesthetics
General anaestheticsGeneral anaesthetics
General anaesthetics
Rani Dhole
 
General anaesthetics
General anaestheticsGeneral anaesthetics
General anaesthetics
Ravish Yadav
 
General anaesthesia
General anaesthesiaGeneral anaesthesia
General anaesthesia
Dr Ravneet Kour
 
9. general anaesthetics
9. general anaesthetics9. general anaesthetics
9. general anaesthetics
Dipak Bari
 
Gen anaesthesia
Gen anaesthesia Gen anaesthesia
Gen anaesthesia
Ansumansahoo15
 
General and Local Anaesthetics drugs.pptx
General and Local Anaesthetics drugs.pptxGeneral and Local Anaesthetics drugs.pptx
General and Local Anaesthetics drugs.pptx
drarunsingh4
 
General Anesthetics
General AnestheticsGeneral Anesthetics
General Anesthetics
FarazaJaved
 
Sedation & Paralysis in ICU- DR.RAGHUNATH ALADAKATTI
Sedation & Paralysis in ICU- DR.RAGHUNATH   ALADAKATTISedation & Paralysis in ICU- DR.RAGHUNATH   ALADAKATTI
Sedation & Paralysis in ICU- DR.RAGHUNATH ALADAKATTIapollobgslibrary
 
'Drug affecting CNS (Anesthetic Drugs.ppt'-converted.pptx
'Drug affecting CNS (Anesthetic Drugs.ppt'-converted.pptx'Drug affecting CNS (Anesthetic Drugs.ppt'-converted.pptx
'Drug affecting CNS (Anesthetic Drugs.ppt'-converted.pptx
PATNIHUSAINIBLOODBAN
 
Malik sedation
Malik sedationMalik sedation
Malik sedation
EM OMSB
 
ga-170603164733.pptx
ga-170603164733.pptxga-170603164733.pptx
ga-170603164733.pptx
chandreshmishra13
 
Art of sedation in icu
Art of sedation in icuArt of sedation in icu
Art of sedation in icu
Surendra Patel
 
GENERAL ANESTHETICS.pptx
GENERAL ANESTHETICS.pptxGENERAL ANESTHETICS.pptx
GENERAL ANESTHETICS.pptx
MuhammadMansoorAlamK
 
General Anaesthetic.pptx
General Anaesthetic.pptxGeneral Anaesthetic.pptx
General Anaesthetic.pptx
Swatiingle7
 
General Anesthetics
General AnestheticsGeneral Anesthetics
General Anesthetics
Vrushank Narola
 
concioussedation-ashishandswati-160104164054.pdf
concioussedation-ashishandswati-160104164054.pdfconcioussedation-ashishandswati-160104164054.pdf
concioussedation-ashishandswati-160104164054.pdf
VelkumarJanakiram
 
Concious Sedation
Concious SedationConcious Sedation
Concious Sedation
princesoni3954
 
General anaesthetics
General anaestheticsGeneral anaesthetics
General anaesthetics
A M O L D E O R E
 
Pharmacotherapeutics of anesthesia ppt
Pharmacotherapeutics of anesthesia pptPharmacotherapeutics of anesthesia ppt
Pharmacotherapeutics of anesthesia ppt
Muhammed Rashid Ak
 

Similar to General anaesthetic (20)

General anaesthetics
General anaestheticsGeneral anaesthetics
General anaesthetics
 
General anaesthetics
General anaestheticsGeneral anaesthetics
General anaesthetics
 
General anaesthesia
General anaesthesiaGeneral anaesthesia
General anaesthesia
 
9. general anaesthetics
9. general anaesthetics9. general anaesthetics
9. general anaesthetics
 
Gen anaesthesia
Gen anaesthesia Gen anaesthesia
Gen anaesthesia
 
General and Local Anaesthetics drugs.pptx
General and Local Anaesthetics drugs.pptxGeneral and Local Anaesthetics drugs.pptx
General and Local Anaesthetics drugs.pptx
 
General Anesthetics
General AnestheticsGeneral Anesthetics
General Anesthetics
 
Sedation & Paralysis in ICU- DR.RAGHUNATH ALADAKATTI
Sedation & Paralysis in ICU- DR.RAGHUNATH   ALADAKATTISedation & Paralysis in ICU- DR.RAGHUNATH   ALADAKATTI
Sedation & Paralysis in ICU- DR.RAGHUNATH ALADAKATTI
 
'Drug affecting CNS (Anesthetic Drugs.ppt'-converted.pptx
'Drug affecting CNS (Anesthetic Drugs.ppt'-converted.pptx'Drug affecting CNS (Anesthetic Drugs.ppt'-converted.pptx
'Drug affecting CNS (Anesthetic Drugs.ppt'-converted.pptx
 
Malik sedation
Malik sedationMalik sedation
Malik sedation
 
ga-170603164733.pptx
ga-170603164733.pptxga-170603164733.pptx
ga-170603164733.pptx
 
Art of sedation in icu
Art of sedation in icuArt of sedation in icu
Art of sedation in icu
 
GENERAL ANESTHETICS.pptx
GENERAL ANESTHETICS.pptxGENERAL ANESTHETICS.pptx
GENERAL ANESTHETICS.pptx
 
General Anaesthetic.pptx
General Anaesthetic.pptxGeneral Anaesthetic.pptx
General Anaesthetic.pptx
 
General Anesthetics
General AnestheticsGeneral Anesthetics
General Anesthetics
 
concioussedation-ashishandswati-160104164054.pdf
concioussedation-ashishandswati-160104164054.pdfconcioussedation-ashishandswati-160104164054.pdf
concioussedation-ashishandswati-160104164054.pdf
 
Concious Sedation
Concious SedationConcious Sedation
Concious Sedation
 
General anaesthetics
General anaestheticsGeneral anaesthetics
General anaesthetics
 
Pharmacotherapeutics of anesthesia ppt
Pharmacotherapeutics of anesthesia pptPharmacotherapeutics of anesthesia ppt
Pharmacotherapeutics of anesthesia ppt
 
General anesthetics(VK)
General anesthetics(VK)General anesthetics(VK)
General anesthetics(VK)
 

More from Kartik Tiwari

Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
Kartik Tiwari
 
Chapter -13, Anti-neoplastic drugs (one page notes).pptx
Chapter -13, Anti-neoplastic drugs (one page notes).pptxChapter -13, Anti-neoplastic drugs (one page notes).pptx
Chapter -13, Anti-neoplastic drugs (one page notes).pptx
Kartik Tiwari
 
MakeIntern IIT Delhi CADD Presentation.pdf
MakeIntern IIT Delhi CADD Presentation.pdfMakeIntern IIT Delhi CADD Presentation.pdf
MakeIntern IIT Delhi CADD Presentation.pdf
Kartik Tiwari
 
Diuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdf
Diuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdfDiuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdf
Diuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdf
Kartik Tiwari
 
Chapter 1 notes Part-2 (One Page Note) Error and limit test .pdf
Chapter 1 notes Part-2 (One Page Note) Error and limit test .pdfChapter 1 notes Part-2 (One Page Note) Error and limit test .pdf
Chapter 1 notes Part-2 (One Page Note) Error and limit test .pdf
Kartik Tiwari
 
Chapter 1 (One Page Note) Definition and errors of Pharmaceutical chemistry.pdf
Chapter 1 (One Page Note) Definition and errors of Pharmaceutical chemistry.pdfChapter 1 (One Page Note) Definition and errors of Pharmaceutical chemistry.pdf
Chapter 1 (One Page Note) Definition and errors of Pharmaceutical chemistry.pdf
Kartik Tiwari
 
Precipitation_titration_mohr's_method_Chart.pptx
Precipitation_titration_mohr's_method_Chart.pptxPrecipitation_titration_mohr's_method_Chart.pptx
Precipitation_titration_mohr's_method_Chart.pptx
Kartik Tiwari
 
Local Anaesthetic (General Overview).pptx
Local Anaesthetic (General Overview).pptxLocal Anaesthetic (General Overview).pptx
Local Anaesthetic (General Overview).pptx
Kartik Tiwari
 
Gravimetric Analysis.pptx
Gravimetric Analysis.pptxGravimetric Analysis.pptx
Gravimetric Analysis.pptx
Kartik Tiwari
 
High Performance Thin Layer Chromatography.pptx
High Performance Thin Layer Chromatography.pptxHigh Performance Thin Layer Chromatography.pptx
High Performance Thin Layer Chromatography.pptx
Kartik Tiwari
 
(Kartik Tiwari) Inorganic Pharmaceutical Chemistry.pptx
(Kartik Tiwari) Inorganic Pharmaceutical Chemistry.pptx(Kartik Tiwari) Inorganic Pharmaceutical Chemistry.pptx
(Kartik Tiwari) Inorganic Pharmaceutical Chemistry.pptx
Kartik Tiwari
 
(Kartik Tiwari) Pharmaceutical Chemistry D.Pharm syllabus orientation..pptx
(Kartik Tiwari) Pharmaceutical Chemistry D.Pharm syllabus orientation..pptx(Kartik Tiwari) Pharmaceutical Chemistry D.Pharm syllabus orientation..pptx
(Kartik Tiwari) Pharmaceutical Chemistry D.Pharm syllabus orientation..pptx
Kartik Tiwari
 
Histaminic Agent.pptx
Histaminic Agent.pptxHistaminic Agent.pptx
Histaminic Agent.pptx
Kartik Tiwari
 
continuous flow reactor M.Pharm .pptx
continuous flow reactor M.Pharm .pptxcontinuous flow reactor M.Pharm .pptx
continuous flow reactor M.Pharm .pptx
Kartik Tiwari
 
Gc-AAS (Gas chromatography - Atomic Absorption Spectroscopy).pptx
Gc-AAS (Gas chromatography - Atomic Absorption Spectroscopy).pptxGc-AAS (Gas chromatography - Atomic Absorption Spectroscopy).pptx
Gc-AAS (Gas chromatography - Atomic Absorption Spectroscopy).pptx
Kartik Tiwari
 
LC-FTIR PPT.pptx S.pptx
LC-FTIR PPT.pptx S.pptxLC-FTIR PPT.pptx S.pptx
LC-FTIR PPT.pptx S.pptx
Kartik Tiwari
 
3D QSAR.pptx
3D QSAR.pptx3D QSAR.pptx
3D QSAR.pptx
Kartik Tiwari
 
Kartik Tiwari microwave ppt.pptx
Kartik Tiwari microwave ppt.pptxKartik Tiwari microwave ppt.pptx
Kartik Tiwari microwave ppt.pptx
Kartik Tiwari
 
Affinity Chromatography MP MPAT Presentation.pptx
Affinity Chromatography MP MPAT Presentation.pptxAffinity Chromatography MP MPAT Presentation.pptx
Affinity Chromatography MP MPAT Presentation.pptx
Kartik Tiwari
 
(Kartik Tiwari) Denovo Drug Design.pptx
(Kartik Tiwari) Denovo Drug Design.pptx(Kartik Tiwari) Denovo Drug Design.pptx
(Kartik Tiwari) Denovo Drug Design.pptx
Kartik Tiwari
 

More from Kartik Tiwari (20)

Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
 
Chapter -13, Anti-neoplastic drugs (one page notes).pptx
Chapter -13, Anti-neoplastic drugs (one page notes).pptxChapter -13, Anti-neoplastic drugs (one page notes).pptx
Chapter -13, Anti-neoplastic drugs (one page notes).pptx
 
MakeIntern IIT Delhi CADD Presentation.pdf
MakeIntern IIT Delhi CADD Presentation.pdfMakeIntern IIT Delhi CADD Presentation.pdf
MakeIntern IIT Delhi CADD Presentation.pdf
 
Diuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdf
Diuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdfDiuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdf
Diuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdf
 
Chapter 1 notes Part-2 (One Page Note) Error and limit test .pdf
Chapter 1 notes Part-2 (One Page Note) Error and limit test .pdfChapter 1 notes Part-2 (One Page Note) Error and limit test .pdf
Chapter 1 notes Part-2 (One Page Note) Error and limit test .pdf
 
Chapter 1 (One Page Note) Definition and errors of Pharmaceutical chemistry.pdf
Chapter 1 (One Page Note) Definition and errors of Pharmaceutical chemistry.pdfChapter 1 (One Page Note) Definition and errors of Pharmaceutical chemistry.pdf
Chapter 1 (One Page Note) Definition and errors of Pharmaceutical chemistry.pdf
 
Precipitation_titration_mohr's_method_Chart.pptx
Precipitation_titration_mohr's_method_Chart.pptxPrecipitation_titration_mohr's_method_Chart.pptx
Precipitation_titration_mohr's_method_Chart.pptx
 
Local Anaesthetic (General Overview).pptx
Local Anaesthetic (General Overview).pptxLocal Anaesthetic (General Overview).pptx
Local Anaesthetic (General Overview).pptx
 
Gravimetric Analysis.pptx
Gravimetric Analysis.pptxGravimetric Analysis.pptx
Gravimetric Analysis.pptx
 
High Performance Thin Layer Chromatography.pptx
High Performance Thin Layer Chromatography.pptxHigh Performance Thin Layer Chromatography.pptx
High Performance Thin Layer Chromatography.pptx
 
(Kartik Tiwari) Inorganic Pharmaceutical Chemistry.pptx
(Kartik Tiwari) Inorganic Pharmaceutical Chemistry.pptx(Kartik Tiwari) Inorganic Pharmaceutical Chemistry.pptx
(Kartik Tiwari) Inorganic Pharmaceutical Chemistry.pptx
 
(Kartik Tiwari) Pharmaceutical Chemistry D.Pharm syllabus orientation..pptx
(Kartik Tiwari) Pharmaceutical Chemistry D.Pharm syllabus orientation..pptx(Kartik Tiwari) Pharmaceutical Chemistry D.Pharm syllabus orientation..pptx
(Kartik Tiwari) Pharmaceutical Chemistry D.Pharm syllabus orientation..pptx
 
Histaminic Agent.pptx
Histaminic Agent.pptxHistaminic Agent.pptx
Histaminic Agent.pptx
 
continuous flow reactor M.Pharm .pptx
continuous flow reactor M.Pharm .pptxcontinuous flow reactor M.Pharm .pptx
continuous flow reactor M.Pharm .pptx
 
Gc-AAS (Gas chromatography - Atomic Absorption Spectroscopy).pptx
Gc-AAS (Gas chromatography - Atomic Absorption Spectroscopy).pptxGc-AAS (Gas chromatography - Atomic Absorption Spectroscopy).pptx
Gc-AAS (Gas chromatography - Atomic Absorption Spectroscopy).pptx
 
LC-FTIR PPT.pptx S.pptx
LC-FTIR PPT.pptx S.pptxLC-FTIR PPT.pptx S.pptx
LC-FTIR PPT.pptx S.pptx
 
3D QSAR.pptx
3D QSAR.pptx3D QSAR.pptx
3D QSAR.pptx
 
Kartik Tiwari microwave ppt.pptx
Kartik Tiwari microwave ppt.pptxKartik Tiwari microwave ppt.pptx
Kartik Tiwari microwave ppt.pptx
 
Affinity Chromatography MP MPAT Presentation.pptx
Affinity Chromatography MP MPAT Presentation.pptxAffinity Chromatography MP MPAT Presentation.pptx
Affinity Chromatography MP MPAT Presentation.pptx
 
(Kartik Tiwari) Denovo Drug Design.pptx
(Kartik Tiwari) Denovo Drug Design.pptx(Kartik Tiwari) Denovo Drug Design.pptx
(Kartik Tiwari) Denovo Drug Design.pptx
 

Recently uploaded

Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 

Recently uploaded (20)

Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 

General anaesthetic

  • 2. ● Outline-: ● General introduction ● Classification of general anaesthetic ● Mode of action ● Stages of anaesthesia ● Drugs - Uses - Contradiction - Dosage - Adverse effect
  • 3. ★ General introduction ● Definition-:General anaesthetic is defined as the chemical agent which causes reversible loss of sensation or unconscious the whole body. ● General anaesthetic is used to unconscious the whole body. ● It act on Central nervous system (CNS) and peripheral parts of the body. ● The characteristics of general anaesthetic are: 1. Unconsciousness 2. Amnesia 3. immobilisation and muscle relaxant.
  • 4. ★ Classification of general anaesthetic General anaesthetic Inhalant Injectable Gaseous Voletile liquids Fast acting drugs Slow acting drugs Benzodiazepines Opioid analgesic Dissociative anaesthetic Nitrous oxide Ether Halothane Isoflurane Desflurane Sevoflurane Thiopentone sod. Methohexitone sod. Propofol Etomidate Diazepam Lorazepam Midazolam Ketamine Fentanyl
  • 5. ● N2O and ketamine do not affect GABA or glycine gated Cl¯ channels. Rather they selectively inhibit the excitatory NMDA type of glutamate receptor. This receptor gates mainly Ca2+ selective cation channels in the neurones, inhibition of which appears to be the primary mechanism of anaesthetic action of keta-mine as well as N2O. The volatile anaesthetics have little action on this receptor. ● Mode of action ● Inhalational anaes-thetics, barbiturates, benzodiazepines and propofol potentiate the action of inhibitory transmitter GABA to open Cl¯ channels.
  • 6. ★ Stages of anaesthesia Modern anesthetics act very rapidly and achieve deep anesthesia quickly. With older and more slowly acting anesthetics, the progressively greater depth of central depression associated with increasing dose or time of exposure is traditionally described as stages of anesthesia. A. Stage 1: Analgesia In stage 1, the patient has decreased awareness of pain, sometimes with amnesia. Consciousness may be impaired but is not lost. B. Stage 2: Disinhibition In stage 2, the patient appears to be delirious and excited. Amnesia occurs, reflexes are enhanced, and respiration is typically irregular; retching and incontinence may occur.
  • 7. C. Stage 3: Surgical Anesthesia In stage 3, the patient is unconscious and has no pain reflexes; respiration is very regular, and blood pressure is maintained. D. Stage 4: Medullary Depression In stage 4, the patient develops severe respiratory and cardiovascular depression that requires mechanical and pharmacologic support. ★ Drugs Halothane Form - Volatile liquid ● Uses: Induction and maintenance of anaesthesia
  • 8. ● Contraindications: History of unexplained jaundice or pyrexia following previous exposure to halothane; family history of malignant hyperthermia; raised cerebrospinal fluid pressure; porphyria ● Precautions: Anaesthetic history should be carefully taken to determine previous exposure and revious reactions to halothane (at least 3 months should be allowed to elapse between each re-exposure); avoid for dental procedures in patients under 18 years unless treated in hospital (high risk of arrhythmias); pregnancy and breastfeeding ● Dosage: Induction, using specifically calibrated vaporizer, gradually increase inspired gas concentration to 2–4% (ADULT ) or 1.5–2% (CHILD ) in oxygen or nitrous oxide–oxygen Maintenance, ADULT and CHILD 0.5–2%
  • 9. ● Adverse effects: arrhythmias; bradycardia; respiratory depression; hepatic damage Nitrous oxide Form - Inhalation gas ● Uses: Maintenance of anaesthesia in combination with other anaesthetic agents (halothane, ether, or ketamine) and muscle relaxants; analgesia for obstetric practice, for emergency management of injuries, during postoperative physiotherapy and for refractory pain in terminal illness ● Contraindications: Demonstrable collection of air in pleural, pericardial or peritoneal space; intestinal obstruction; occlusion of middle ear; arterial air embolism; decompression sickness; chronic obstructive airway disease, emphysema
  • 10. ● Dosage: Anaesthesia, Adult and Child nitrous oxide mixed with 25–30% oxygen Analgesia, 50% nitrous oxide mixed with 50% oxygen ● Adverse effects: nausea and vomiting; after prolonged administration megaloblastic anaemia, depressed white cell formation; peripheral neuropathy Thiopental sodium Thiopental is a representative intravenous anaesthetic. Various drugs can serve as alternatives Injection (Powder for solution for injection), thiopental sodium, 0.5-g and 1-g ampoules. ● Uses: Induction of anaesthesia prior to administration of inhalational anaesthetic; anaesthesia of short duration ● Contraindications: Inability to maintain airway; hypersensitivity to barbiturates;
  • 11. ● Dosage: Induction, by intravenous injection as a 2.5% (25 mg/ml) solution over 10–15 seconds, Adult 100–150 mg (reduced in elderly or debilitated patients), followed by a further 100–150 mg if necessary according to response after 60 seconds; or up to 4 mg/kg; Child 2–7 mg/kg repeated if necessary according to response after 60 seconds. Form - Volatile liquid ● Uses: Induction and maintenance of anaesthesia (administered from many types of vaporizers) ● Contraindications: severe liver disease; diabetes mellitus; impaired kidney function; raised cerebrospinal fluid pressure. Ether, anaesthetic
  • 12. ● Dosage: Induction, Adult and Child , up to 15% in inspired gases Maintenance of light anaesthesia, Adult and Child 3–5% in air (with or without muscle relaxants); up to 10% for deep anaesthesia ● Adverse effects: transient postoperative effects include impairment of liver function and leukocytosis; nausea and vomiting; capillary bleeding.